KAREN A DAWES Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KAREN A DAWES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KAREN A DAWES. KAREN A DAWES is a Director in PDL BIOPHARMA, INC. ($PDLI) and a Director in REPLIGEN CORP ($RGEN) and a Director in DEPOMED INC ($DMI) and a Director in Vaccitech plc ($VACC).
Address: C/O PROTEIN DESIGN LABS, INC. 34801 CAMPUS DRIVE FREMONT 94555 CA
Companies in which KAREN A DAWES is an Insider
Assertio Therapeutics, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KAREN A DAWES: Director
Holdings: 84,589 shares
Latest Transaction: May 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KAREN A DAWES: Director
Holdings: 2,000 shares
Current Value: $4,420
Latest Transaction: Oct 03 2005
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REPLIGEN CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KAREN A DAWES: Director
Holdings: 115,734 shares
Current Value: $3,384,062
Latest Transaction: May 13 2021
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vaccitech plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KAREN A DAWES: Director
Holdings: 1,700 shares
Latest Transaction: May 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KAREN A DAWES
Sentiment: All, DMI, PDLI, RGEN, VACC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Option Exercise | M | 3.22 | 15,000 | 48,300 | 0 | |
| May 13 2021 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 176.85 | 285 | 50,402 | 115,449 | 115.7 K to 115.4 K (-0.25 %) |
| May 13 2021 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Buy | M | 3.22 | 15,000 | 48,300 | 115,734 | 100.7 K to 115.7 K (+14.89 %) |
| May 06 2021 | VACC | Vaccitech plc | DAWES KAREN A | Director | Buy | P | 17.00 | 1,700 | 28,900 | 1,700 | 0 to 1.7 K |
| May 04 2021 | VACC | Vaccitech plc | DAWES KAREN A | Director | Option Exercise | A | 17.00 | 34,328 | 583,576 | 34,328 | |
| Jun 22 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 116.56 | 2,568 | 299,326 | 100,734 | 103.3 K to 100.7 K (-2.49 %) |
| Jun 22 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 115.76 | 8,217 | 951,200 | 103,302 | 111.5 K to 103.3 K (-7.37 %) |